Insulin
Authors:
- Mario ThevisMTMario Thevis
- Andreas ThomasATAndreas Thomas
- Wilhelm SchänzerWSWilhelm Schänzer
- 17 September 2009
- book chapter
- Published by Springer Nature
- Vol. 15 (195) , 209-226
Abstract
Due to its versatile nature and its corresponding anabolic and anticatabolic properties, insulin has been prohibited in sports since 1999. Numerous studies concerning its impact on glycogen formation, protein biosynthesis, and inhibition of protein breakdown have illustrated its importance for healthy humans and diabetics as well as elite athletes. Various reports described the misuse of insulin to improve performance and muscle strength, and synthetic analogs were the subject of several studies describing the beneficial effects of biotechnologically modified insulins. Rapid- or long-acting insulins were developed to enhance the injection-to-onset profile as well as the controllability of administered insulin, where the slightest alterations in primary amino acid sequences allowed the inhibition of noncovalent aggregation of insulin monomers (rapid-acting analogs) or promoted microprecipitation of insulin variants upon subcutaneous application (long-acting analogs). Information on the metabolic fate and renal elimination of insulins has been rather limited, and detection assays for doping control purposes were primarily established using the intact compounds as target analytes in plasma and urine specimens. However, recent studies revealed the presence of urinary metabolites that have been implemented in confirmation methods of sports drug testing procedures. So far, no screening tool is available providing fast and reliable information on possible insulin misuse; only sophisticated procedures including immunoaffinity purification followed by liquid chromatography and tandem mass spectrometry have enabled the unambiguous detection of synthetic insulins in doping control blood or urine samples.Keywords
This publication has 60 references indexed in Scilit:
- Mass spectrometric identification of peptide hormones in doping-control analysisThe Analyst, 2007
- Strong diabetesBritish Journal of Sports Medicine, 2007
- Mass Spectrometric Identification of Degradation Products of Insulin and Its Long-Acting Analogues in Human Urine for Doping Control PurposesAnalytical Chemistry, 2007
- Effect of insulin on human skeletal muscle protein synthesis is modulated by insulin-induced changes in muscle blood flow and amino acid availabilityAmerican Journal of Physiology-Endocrinology and Metabolism, 2006
- Hyperinsulinaemia, hyperaminoacidaemia and post-exercise muscle anabolism: the search for the optimal recovery drinkBritish Journal of Sports Medicine, 2006
- Qualitative Determination of Synthetic Analogues of Insulin in Human Plasma by Immunoaffinity Purification and Liquid Chromatography−Tandem Mass Spectrometry for Doping Control PurposesAnalytical Chemistry, 2005
- Insulin Use by BodybuildersJAMA, 1998
- Self-induced insulin hypoglycemia in a bodybuilderArchives of internal medicine (1960), 1994
- Physiology and Pathophysiology of Insulin SecretionDiabetes Care, 1990
- SomatostatinNew England Journal of Medicine, 1983